Antiviral and antibiotic prescribing for influenza in primary care
- PMID: 19225847
- PMCID: PMC2659164
- DOI: 10.1007/s11606-009-0933-9
Antiviral and antibiotic prescribing for influenza in primary care
Abstract
Background: Anti-influenza antiviral medications reduce influenza-related morbidity, but may often be used inappropriately.
Objective: To measure the rate of antiviral and antibiotic prescribing, the appropriateness of antiviral prescribing, and evaluate independent predictors of antiviral and antibiotic prescribing for influenza in primary care.
Design and patients: Retrospective analysis of 958 visits of clinician-diagnosed influenza in 21 primary care clinics in eastern Massachusetts from 1999 to 2007. We considered antiviral prescribing appropriate if patients had symptoms for 2 or fewer days, had fever, and any 2 of headache, sore throat, cough, or myalgias.
Measurements and main results: Clinicians prescribed antivirals in 557 (58%) visits and antibiotics in 104 visits (11%). Of antiviral prescriptions, 38% were not appropriate, most commonly because of symptoms for more than 2 days (24% of antiviral prescriptions). In multivariate modeling, selected independent predictors of antiviral prescribing were symptom duration of 2 or fewer days (odds ratio [OR], 12.4; 95% confidence interval [CI], 8.3 to 18.6), year (OR, 1.4 for each successive influenza season; 95% CI, 1.3 to 1.7), patient age (OR, 1.3 per decade; 95% CI, 1.2 to 1.5), and, compared to having no influenza testing, having a negative influenza test (OR, 5.5; 95% CI, 3.4 to 9.1) or a positive influenza test (OR, 11.4; 95% CI, 6.7 to 19.3). Independent predictors of antibiotic prescribing included otoscopic abnormalities (OR, 3.3; 95% CI, 1.8 to 6.0), abnormal lung examination (OR, 4.0; 95% CI, 2.1 to 6.2), and having a chest x-ray performed (OR, 2.2; 95% CI, 1.3 to 3.8).
Conclusions: Primary care clinicians are much more likely to prescribe antivirals to patients with symptoms for 2 or fewer days, but also commonly prescribe antivirals inappropriately.
Figures
Similar articles
-
Appropriateness of antiviral prescribing for influenza in primary care: a retrospective analysis.J Clin Pharm Ther. 2006 Jun;31(3):245-52. doi: 10.1111/j.1365-2710.2006.00731.x. J Clin Pharm Ther. 2006. PMID: 16789990
-
Antivirals and antibiotics for influenza in the United States, 1995--2002.Pharmacoepidemiol Drug Saf. 2005 Aug;14(8):531-6. doi: 10.1002/pds.1067. Pharmacoepidemiol Drug Saf. 2005. PMID: 15654722
-
Influenza antiviral treatment in spinal cord injury patients, 2007-2010.J Spinal Cord Med. 2015 Jan;38(1):48-56. doi: 10.1179/2045772314Y.0000000237. Epub 2014 Jun 24. J Spinal Cord Med. 2015. PMID: 24961594 Free PMC article.
-
Delayed antibiotics for respiratory infections.Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004417. doi: 10.1002/14651858.CD004417.pub4. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Sep 07;9:CD004417. doi: 10.1002/14651858.CD004417.pub5. PMID: 23633320 Updated. Review.
-
Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection.Rev Med Virol. 2018 Sep;28(5):e1995. doi: 10.1002/rmv.1995. Epub 2018 Aug 13. Rev Med Virol. 2018. PMID: 30101552 Free PMC article. Review.
Cited by
-
The Impact of Point-of-Care Testing for Influenza on Antimicrobial Stewardship (PIAMS) in UK Primary Care: Protocol for a Mixed Methods Study.JMIR Res Protoc. 2023 Jun 16;12:e46938. doi: 10.2196/46938. JMIR Res Protoc. 2023. PMID: 37327029 Free PMC article.
-
Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study.JMIR Res Protoc. 2019 Nov 11;8(11):e14186. doi: 10.2196/14186. JMIR Res Protoc. 2019. PMID: 31710303 Free PMC article.
-
Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016.Open Forum Infect Dis. 2019 Apr 26;6(6):ofz192. doi: 10.1093/ofid/ofz192. eCollection 2019 Jun. Open Forum Infect Dis. 2019. PMID: 31205973 Free PMC article.
-
Are Rapid Influenza Antigen Tests Still Clinically Useful in Today's Molecular Diagnostics World?Hawaii J Med Public Health. 2018 Sep;77(9):226-230. Hawaii J Med Public Health. 2018. PMID: 30221077 Free PMC article.
-
Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.Influenza Other Respir Viruses. 2016 Mar;10(2):113-21. doi: 10.1111/irv.12359. Epub 2016 Jan 29. Influenza Other Respir Viruses. 2016. PMID: 26574910 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '17625497', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17625497/'}]}
- Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR. 2007;56(RR-6):1–54. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMcp0807498', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmcp0807498'}, {'type': 'PubMed', 'value': '19073977', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/19073977/'}]}
- Glezen WP. Prevention and treatment of seasonal influenza. New Engl J Med. 2008;359(24):2579–2585. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/archinte.161.2.212', 'is_inner': False, 'url': 'https://doi.org/10.1001/archinte.161.2.212'}, {'type': 'PubMed', 'value': '11176734', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11176734/'}]}
- Lalezari J, Campion K, Keene O, Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med. 2001;161(2):212–217. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8855992', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8855992/'}]}
- Libow LS, Neufeld RR, Olson E, Breuer B, Starer P. Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine. J Am Geriatr Soc. 1996;44(10):1153–1157. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1046/j.1532-5415.2002.50153.x', 'is_inner': False, 'url': 'https://doi.org/10.1046/j.1532-5415.2002.50153.x'}, {'type': 'PubMed', 'value': '11982659', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11982659/'}]}
- Bowles SK, Lee W, Simor AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc. 2002;50(4):608–616. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
